Development and validation of a high performance liquid chromatography-tandem mass spectrometry for the determination of etodolac in human plasma

J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Feb 15;863(1):158-62. doi: 10.1016/j.jchromb.2007.11.032. Epub 2007 Dec 4.

Abstract

A simple and specific method using a one-step liquid-liquid extraction (LLE) with butyl acetate followed by high performance liquid chromatography (HPLC) coupled with positive ion electrospray ionization tandem mass spectrometry (ESI-MS/MS) detection was developed for the determination of etodolac in human plasma, using indomethacin as an internal standard (IS). Chromatographic separation was performed isocratically using a Capcellpak MGII C(18) column with 65% acetonitrile and 35% water containing 10mM ammonium formate (adjusted to pH 3.5 with formic acid). Acquisition was performed in multiple reaction monitoring (MRM) mode by monitoring the transitions: m/z 287.99>172.23 for etodolac and m/z 357.92>139.01 for IS. The method was validated to determine its selectivity, linearity, sensitivity, precision, accuracy, recovery and stability. The limit of quantitation (LLOQ) was 0.1microg/mL with a relative standard deviation of less than 15%. The devised method provides an accurate, precise and sensitive tool for determining etodolac levels in plasma.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / blood*
  • Calibration
  • Chromatography, High Pressure Liquid
  • Etodolac / blood*
  • Humans
  • Indomethacin / blood
  • Indomethacin / pharmacokinetics
  • Quality Control
  • Reproducibility of Results
  • Tandem Mass Spectrometry

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Etodolac
  • Indomethacin